Vaccine
stringclasses 11
values | Dose
stringclasses 9
values | Geography Type
stringclasses 2
values | Geography
stringclasses 79
values | Birth Year/Birth Cohort
stringclasses 21
values | Dimension Type
stringclasses 6
values | Dimension
stringclasses 26
values | Estimate (%)
float64 4.7
100
⌀ | 95% CI (%)
stringlengths 10
13
⌀ | Sample Size
int64 9
63.4k
⌀ |
|---|---|---|---|---|---|---|---|---|---|
Hep A | ≥1 Dose | States/Local Areas | North Dakota | 2014-2017 | Race and Ethnicity | White, Non-Hispanic | 90 | 87.3 to 92.7 | 637 |
Hep A | ≥1 Dose | States/Local Areas | North Dakota | 2014-2017 | Urbanicity | Living In a MSA Principal City | 90.2 | 86.2 to 94.2 | 285 |
Hep A | ≥1 Dose | States/Local Areas | North Dakota | 2014-2017 | Urbanicity | Living In a MSA Non-Principal City | 85.2 | 78.1 to 92.2 | 124 |
Hep A | ≥1 Dose | States/Local Areas | North Dakota | 2014-2017 | Urbanicity | Living In a Non-MSA | 90.2 | 86.9 to 93.5 | 421 |
Hep A | ≥1 Dose | States/Local Areas | North Dakota | 2014-2017 | Race and Ethnicity | Other or Multiple Races, Non-Hispanic | 87.6 | 80.8 to 94.5 | 123 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2015 | Age | 13 Months | 67.5 | 59.9 to 74.2 | 217 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2015-2016 | Age | 13 Months | 67.8 | 62.4 to 72.8 | 444 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2017 | Age | 13 Months | 63.9 | 56.6 to 70.7 | 298 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2017-2018 | Age | 13 Months | 65.2 | 59.7 to 70.3 | 591 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2016 | Age | 13 Months | 68.1 | 60.2 to 75.1 | 227 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2016-2017 | Age | 13 Months | 66.1 | 60.8 to 71.0 | 525 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2017 | Age | 24 Months | 77.2 | 70.5 to 83.4 | 298 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2017-2018 | Age | 24 Months | 82.2 | 77.7 to 86.2 | 591 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2018 | Age | 24 Months | 87.5 | 81.9 to 92.1 | 293 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2018-2019 | Age | 24 Months | 85 | 80.7 to 88.7 | 556 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2011 | Age | 35 Months | 84.1 | 76.0 to 90.6 | 299 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2019 | Age | 24 Months | 82.4 | 75.9 to 88.0 | 263 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2014-2017 | Poverty | <133% FPL | 81.7 | 72.1 to 91.3 | 155 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2014-2017 | Overall | Overall | 86.2 | 82.2 to 90.2 | 830 |
Polio | ≥2 Doses | States/Local Areas | North Dakota | 2019 | Age | 7 Months | 90.5 | 85.0 to 94.1 | 263 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2014-2017 | Urbanicity | Living In a MSA Non-Principal City | 79.9 | 69.5 to 90.4 | 124 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2014-2017 | Urbanicity | Living In a Non-MSA | 82.7 | 76.3 to 89.0 | 421 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2014-2017 | Race and Ethnicity | White, Non-Hispanic | 86.1 | 81.5 to 90.7 | 637 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2011 | Age | 13 Months | 57.2 | 50.8 to 63.3 | 299 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2012 | Age | 13 Months | 62.7 | 57.8 to 67.4 | 294 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2013 | Age | 13 Months | 60.3 | 50.5 to 69.3 | 237 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2013-2014 | Age | 13 Months | 62.9 | 61.2 to 64.6 | 467 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2017 | Age | 35 Months | 78.6 | 70.8 to 85.5 | 298 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2017-2018 | Age | 35 Months | 78.5 | 72.6 to 83.9 | 591 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2018 | Age | 35 Months | 78.3 | 69.2 to 86.2 | 293 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2018-2019 | Age | 35 Months | 82.5 | 76.5 to 87.7 | 556 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2014 | Age | 13 Months | 91.6 | 86.8 to 94.8 | 230 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2014-2015 | Age | 13 Months | 93.5 | 90.6 to 95.5 | 447 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2013 | Age | 13 Months | 88.3 | 68.8 to 96.3 | 237 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2013-2014 | Age | 13 Months | 90.1 | 82.9 to 94.4 | 467 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2013 | Age | 35 Months | 83 | 75.4 to 89.3 | 237 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2013-2014 | Age | 35 Months | 88.8 | 84.3 to 92.5 | 467 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2012 | Age | 13 Months | 89.2 | 85.0 to 92.3 | 294 |
Hep A | ≥2 Doses | States/Local Areas | North Dakota | 2019 | Age | 35 Months | 86.8 | 79.0 to 92.8 | 263 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2014 | Age | 35 Months | 94 | 89.0 to 97.2 | 230 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2014-2015 | Age | 35 Months | 92.6 | 89.2 to 95.3 | 447 |
DTaP | ≥4 Doses | States/Local Areas | North Dakota | 2012 | Age | 35 Months | 87.2 | 80.6 to 92.3 | 294 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2018 | Age | 13 Months | 66.6 | 58.3 to 74.0 | 293 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2018-2019 | Age | 13 Months | 67.5 | 61.8 to 72.6 | 556 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2016 | Age | 13 Months | 68.5 | 60.7 to 75.5 | 227 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2016-2017 | Age | 13 Months | 67.8 | 62.6 to 72.7 | 525 |
PCV | ≥4 Doses | States/Local Areas | North Dakota | 2020 | Age | 35 Months | 82.5 | 75.0 to 88.8 | 248 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2012 | Age | 19 Months | 88.7 | 86.3 to 90.7 | 294 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2011 | Age | 19 Months | 83.2 | 80.2 to 85.9 | 299 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2019 | Age | 13 Months | 68.4 | 60.7 to 75.2 | 263 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2015 | Age | 13 Months | 71.5 | 64.3 to 77.8 | 217 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2015-2016 | Age | 13 Months | 70.1 | 64.7 to 74.9 | 444 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2014 | Age | 13 Months | 65.4 | 57.3 to 72.7 | 230 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2014-2015 | Age | 13 Months | 68.4 | 63.0 to 73.4 | 447 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2018 | Age | 7 Months | 95.3 | 91.6 to 97.4 | 293 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2018-2019 | Age | 7 Months | 95.5 | 93.2 to 97.1 | 556 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | North Dakota | 2019 | Age | 0-2 Days | 86.2 | 79.1 to 91.2 | 263 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | North Dakota | 2018 | Age | 0-2 Days | 84.9 | 78.3 to 89.7 | 293 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | North Dakota | 2018-2019 | Age | 0-2 Days | 85.5 | 80.8 to 89.2 | 556 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | North Dakota | 2017 | Age | 0-2 Days | 81.8 | 75.1 to 87.0 | 298 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | North Dakota | 2017-2018 | Age | 0-2 Days | 83.3 | 78.8 to 87.0 | 591 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2017 | Age | 35 Months | 92.7 | 87.6 to 96.2 | 298 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2017-2018 | Age | 35 Months | 95.2 | 91.9 to 97.4 | 591 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2018 | Age | 35 Months | 97.2 | 93.4 to 99.1 | 293 |
≥1 Dose Varicella | null | States/Local Areas | North Dakota | 2018-2019 | Age | 35 Months | 94.7 | 91.4 to 97.0 | 556 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2015 | Age | 7 Months | 96.5 | 93.6 to 98.1 | 217 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2015-2016 | Age | 7 Months | 95.4 | 93.0 to 97.0 | 444 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2018 | Age | 24 Months | 95.3 | 91.6 to 97.7 | 293 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2018-2019 | Age | 24 Months | 95.9 | 93.6 to 97.5 | 556 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2015 | Age | 13 Months | 91.9 | 87.1 to 95.0 | 217 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2015-2016 | Age | 13 Months | 91 | 87.5 to 93.6 | 444 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2014 | Age | 13 Months | 90.7 | 85.7 to 94.1 | 230 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2014-2015 | Age | 13 Months | 91.3 | 88.0 to 93.8 | 447 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2017 | Age | 7 Months | 92.7 | 88.4 to 95.5 | 298 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2017-2018 | Age | 7 Months | 94 | 91.3 to 95.9 | 591 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2013 | Age | 13 Months | 83.4 | 62.7 to 93.8 | 237 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2013-2014 | Age | 13 Months | 87.2 | 79.4 to 92.4 | 467 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2016 | Age | 7 Months | 94.3 | 90.4 to 96.6 | 227 |
Hep B | ≥2 Doses | States/Local Areas | North Dakota | 2016-2017 | Age | 7 Months | 93.5 | 90.8 to 95.5 | 525 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | North Dakota | 2016 | Age | 0-2 Days | 81.6 | 74.2 to 87.2 | 227 |
Hep B | ≥1 Dose, 2 Day | States/Local Areas | North Dakota | 2016-2017 | Age | 0-2 Days | 81.7 | 76.9 to 85.7 | 525 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2014 | Age | 24 Months | 92.9 | 88.7 to 96.0 | 230 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2014-2015 | Age | 24 Months | 94.1 | 91.6 to 96.1 | 447 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2015 | Age | 24 Months | 95.3 | 92.1 to 97.5 | 217 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2015-2016 | Age | 24 Months | 94.3 | 91.7 to 96.3 | 444 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2016 | Age | 24 Months | 93.2 | 89.2 to 96.1 | 227 |
Hep B | ≥3 Doses | States/Local Areas | North Dakota | 2016-2017 | Age | 24 Months | 93.5 | 90.8 to 95.6 | 525 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2012 | Age | 13 Months | 90.2 | 86.6 to 92.9 | 294 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2016 | Age | 24 Months | 92.1 | 87.7 to 95.4 | 227 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2016-2017 | Age | 24 Months | 93.2 | 90.5 to 95.4 | 525 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2017 | Age | 24 Months | 94.4 | 90.9 to 96.9 | 298 |
≥1 Dose MMR | null | States/Local Areas | North Dakota | 2017-2018 | Age | 24 Months | 94.9 | 92.5 to 96.8 | 591 |
PCV | ≥4 Doses | States/Local Areas | North Dakota | 2018 | Age | 19 Months | 89.2 | 83.7 to 93.1 | 293 |
PCV | ≥4 Doses | States/Local Areas | North Dakota | 2018-2019 | Age | 19 Months | 85.6 | 80.2 to 89.7 | 462 |
PCV | ≥4 Doses | States/Local Areas | North Dakota | 2017 | Age | 19 Months | 77.5 | 70.5 to 83.3 | 298 |
PCV | ≥4 Doses | States/Local Areas | North Dakota | 2017-2018 | Age | 19 Months | 83.2 | 78.8 to 86.9 | 591 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2011 | Age | 13 Months | 86.6 | 83.9 to 88.8 | 299 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2019 | Age | 7 Months | 80.2 | 73.4 to 85.6 | 263 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2018 | Age | 7 Months | 78.5 | 71.4 to 84.3 | 293 |
PCV | ≥3 Doses | States/Local Areas | North Dakota | 2018-2019 | Age | 7 Months | 79.4 | 74.6 to 83.5 | 556 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.